Literature DB >> 28286383

The Efficacy of Platelets Rich Plasma Injection in the Superior Joint Space of the Tempromandibular Joint Guided by Ultra Sound in Patients with Non-reducing Disk Displacement.

Ra'ed M Ayoub Al-Delayme1,2,3, Shefaa H Alnuamy4, Firas Taha Hamid5, Tariq Jassim Azzamily6, Salah AbdulMahdy Ismaeel2, R Sammir7, M Hadeel7, Jafaar Nabeel7, R Shwan7, Shahad Jamal Alfalahi7, Alaa Yasin8.   

Abstract

OBJECTIVE: The objective of this study was to determine average improvement during the rest and active mouth opening after ultrasound guided platelets rich plasma injection in the tempromandibular superior joint space for the patients complaining from non-reducing disk displacement. PATIENTS AND METHODS: Thirty-four patients with non-reducing disk displacement underwent guided ultrasound injection of platelet rich plasma to the upper joint space. The extent of maximal mouth opening, chewing efficiency, sound intensity of the TMJ, and tenderness of the TMJ and the masticatory muscles at rest, motion and mastication were thoroughly assessed at the beginning of the study and scheduled for next follow-up at 1st, 3rd, and 6th months.
RESULTS: Injection with platelets rich plasma was significantly more effective in improvements of the extent of maximal mouth opening, statistics result demonstrated a significant reduction in the VAS values of pain at rest, motion and mastication compared to the baseline VAS values.
CONCLUSION: PRP injection to the upper temporomandibular joint space provided improvement in signs and symptoms of patient with non-reducing disk displacement of the temporomandibular joint.

Entities:  

Keywords:  Clinical outcome; Non-reducing disk displacement; Platelets rich plasma; Risk factor; Superior joint space; Temporomandibular joint

Year:  2016        PMID: 28286383      PMCID: PMC5328864          DOI: 10.1007/s12663-016-0911-9

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  27 in total

1.  Effectiveness of a combination of platelet-rich plasma, bovine porous bone mineral and guided tissue regeneration in the treatment of mandibular grade II molar furcations in humans.

Authors:  Vojislav Lekovic; Paulo M Camargo; Michael Weinlaender; Nikola Vasilic; Zoran Aleksic; E Barrie Kenney
Journal:  J Clin Periodontol       Date:  2003-08       Impact factor: 8.728

2.  Arthrocentesis for temporomandibular joint pain dysfunction syndrome.

Authors:  Peter A Brennan; Vellupillai Ilankovan
Journal:  J Oral Maxillofac Surg       Date:  2006-06       Impact factor: 1.895

3.  Prevalence of morphological changes in the surfaces of the temporomandibular joint disc associated with internal derangement.

Authors:  T Kondoh; P L Westesson; T Takahashi; K Seto
Journal:  J Oral Maxillofac Surg       Date:  1998-03       Impact factor: 1.895

Review 4.  Potential applications of hyaluronans in orthopaedics: degenerative joint disease, surgical recovery, trauma and sports injuries.

Authors:  Michael J Axe; Clarence L Shields
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 5.  Intra-articular injections with corticosteroids and sodium hyaluronate for treating temporomandibular joint disorders: a systematic review.

Authors:  Eduardo Machado; Daniel Bonotto; Paulo Afonso Cunali
Journal:  Dental Press J Orthod       Date:  2013 Sep-Oct

6.  Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid.

Authors:  Tímea Spaková; Ján Rosocha; Marek Lacko; Denisa Harvanová; Ahmed Gharaibeh
Journal:  Am J Phys Med Rehabil       Date:  2012-05       Impact factor: 2.159

7.  Mood and anxiety psychopathology and temporomandibular disorder: a spectrum approach.

Authors:  D Manfredini; A Bandettini di Poggio; E Cantini; L Dell'Osso; M Bosco
Journal:  J Oral Rehabil       Date:  2004-10       Impact factor: 3.837

8.  Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions.

Authors:  Elizaveta Kon; Roberto Buda; Giuseppe Filardo; Alessandro Di Martino; Antonio Timoncini; Annarita Cenacchi; Pier Maria Fornasari; Sandro Giannini; Maurilio Marcacci
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-10-17       Impact factor: 4.342

9.  Orofacial pain of psychogenic origin: current concepts and classification.

Authors:  S F Dworkin; J A Burgess
Journal:  J Am Dent Assoc       Date:  1987-10       Impact factor: 3.634

10.  Temporomandibular joint osteoarthritis: an open label trial of 76 patients treated with arthrocentesis plus hyaluronic acid injections.

Authors:  D Manfredini; S Bonnini; R Arboretti; L Guarda-Nardini
Journal:  Int J Oral Maxillofac Surg       Date:  2009-04-29       Impact factor: 2.789

View more
  4 in total

1.  "RA.DI.CA." Splint for the Management of the Mandibular Functional Limitation: A Retrospective Study on Patients with Anterior Disc Displacement without Reduction.

Authors:  Carlo Di Paolo; Giovanni Falisi; Fabrizio Panti; Paola Di Giacomo; Alessandro Rampello
Journal:  Int J Environ Res Public Health       Date:  2020-12-04       Impact factor: 3.390

2.  Treatment of temporomandibular joint disc displacement using arthrocentesis combined with injectable platelet rich fibrin versus arthrocentesis alone.

Authors:  Nahed Ibrahim Ghoneim; Noha Ahmed Mansour; Sarah Ahmed Elmaghraby; Sally Elsayed Abdelsameaa
Journal:  J Dent Sci       Date:  2021-08-21       Impact factor: 2.080

3.  Comparison of intraarticular injection of platelet-rich plasma following arthrocentesis, with sodium hyaluronate and conventional arthrocentesis for management of internal derangement of temporomandibular joint.

Authors:  Divya Sanjeevi Ramakrishnan; Janani Kandamani; K P Senthil Nathan
Journal:  Natl J Maxillofac Surg       Date:  2022-06-15

4.  Repeated Intra-Articular Administration of Platelet-Rich Plasma (PRP) in Temporomandibular Disorders: A Clinical Case Series.

Authors:  Maciej Sikora; Marcin Sielski; Maciej Chęciński; Zuzanna Nowak; Barbara Czerwińska-Niezabitowska; Dariusz Chlubek
Journal:  J Clin Med       Date:  2022-07-22       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.